These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Atypical granulocytopenia in clozapine treatment]. Hohl U, Hoffmann-Richter U. Psychiatr Prax; 1993 Nov; 20(6):232-3. PubMed ID: 8310097 [No Abstract] [Full Text] [Related]
24. A review of clozapine: an antipsychotic for treatment-resistant schizophrenia. Stephens P. Compr Psychiatry; 1990 Nov; 31(4):315-26. PubMed ID: 2201482 [Abstract] [Full Text] [Related]
25. FDA's position on the clozaril patient management system. Peck CC. Hosp Community Psychiatry; 1990 Aug; 41(8):876-7. PubMed ID: 2401475 [No Abstract] [Full Text] [Related]
26. Clozapine and electroconvulsive therapy. Fink M. Arch Gen Psychiatry; 1990 Mar; 47(3):290-1. PubMed ID: 1968331 [No Abstract] [Full Text] [Related]
27. Clozapine: the commitment to patient safety. Alphs LD, Anand R. J Clin Psychiatry; 1999 Mar; 60 Suppl 12():39-42. PubMed ID: 10372610 [Abstract] [Full Text] [Related]
28. Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study. Gelenberg AJ, Doller JC. J Clin Psychiatry; 1979 May; 40(5):238-40. PubMed ID: 374401 [Abstract] [Full Text] [Related]
29. Stability of neurological signs with clozapine treatment. Buchanan RW, Koeppl P, Breier A. Biol Psychiatry; 1994 Aug 01; 36(3):198-200. PubMed ID: 7948457 [No Abstract] [Full Text] [Related]
30. Do anticonvulsants hinder clozapine treatment? Wilson WH. Biol Psychiatry; 1995 Jan 15; 37(2):132-3. PubMed ID: 7718678 [No Abstract] [Full Text] [Related]
31. [Weight gain and clozapine]. Jalenques I, Tauveron I, Albuisson E, Audy V. Encephale; 1996 Oct 15; 22 Spec No 3():77-9. PubMed ID: 8954282 [No Abstract] [Full Text] [Related]
32. Clozapine for the treatment of adolescents with schizophrenia. Birmaher B, Baker R, Kapur S, Quintana H, Ganguli R. J Am Acad Child Adolesc Psychiatry; 1992 Jan 15; 31(1):160-4. PubMed ID: 1537770 [Abstract] [Full Text] [Related]
33. Clinical efficacy of clozapine in the treatment of schizophrenia. Meltzer HY, Alphs LD, Bastani B, Ramirez LF, Kwon K. Pharmacopsychiatry; 1991 Mar 15; 24(2):44-5. PubMed ID: 1852789 [No Abstract] [Full Text] [Related]
34. Schizophrenia: recent advances in psychopharmacology. Sharma T. Br J Hosp Med; 1991 Mar 15; 55(4):194-8. PubMed ID: 8777500 [No Abstract] [Full Text] [Related]
35. Cost-effectiveness of clozapine monitoring after the first 6 months. Zhang M, Owen RR, Pope SK, Smith GR. Arch Gen Psychiatry; 1996 Oct 15; 53(10):954-8. PubMed ID: 8857873 [Abstract] [Full Text] [Related]
36. Antipsychotic medication in the treatment of schizophrenia. Kane JM. Isr J Psychiatry Relat Sci; 1995 Oct 15; 32(1):30-7. PubMed ID: 7542642 [Abstract] [Full Text] [Related]
37. Monitoring clozapine. Meltzer HY. Hosp Community Psychiatry; 1990 Dec 15; 41(12):1356-7. PubMed ID: 2125973 [No Abstract] [Full Text] [Related]
38. Clozapine for refractory schizophrenia: the Illinois experience. Buckman RW, Malan RD. J Clin Psychiatry; 1999 Dec 15; 60 Suppl 1():18-22; discussion 28-30. PubMed ID: 10037166 [Abstract] [Full Text] [Related]
39. Unsuccessful reexposure to clozapine. Frankenburg FR, Stormberg D, Gerson SL. J Clin Psychopharmacol; 1994 Dec 15; 14(6):428-9. PubMed ID: 7884027 [No Abstract] [Full Text] [Related]
40. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia. Meltzer HY, Cola P, Way L, Thompson PA, Bastani B, Davies MA, Snitz B. Am J Psychiatry; 1993 Nov 15; 150(11):1630-8. PubMed ID: 8105705 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]